Loading…
Login
Scholar Register
Business Register
Subscribe
Loading…
Article Title
Abstract
Keyword
Category
MESH Heading
Grant Agency
RCAID
DOI
PMID
PMCID
Author
Affiliation
Email
Journal Title
ISSN
Publisher
Loading…
Contains
Equals
Find an Article
Find an Article (55395249)
Find a Category (124)
Find a Journal (6149)
Find a Scholar (3999)
Find an Academic Assistant (18)
Find an Article PDF (4617274)
Today's Articles (4784)
Subscriber (49398)
Citation(s) in
RCA
1
(from Reference Citation Analysis)
Indexed Articles
Today (0)
Yesterday (0)
This Week (0)
Last Week (0)
Current Month (0)
Last Month (0)
Ranked By
Impact Index Per Article
Citation(s) in
RCA
Results Analysis
Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis
Results Analysis
Year Published
2022 (1)
Show more
Refine
Article Statistics
Open (1)
PubMed (1)
RCA (1)
SCIE (1)
Refine
Publication Titles
CELLS (1)
Show more
Refine
Category
Biology (1)
Cell Biology (1)
Show more
Refine
For:
Fang R
, Xia QY, Wang XT, Pan R, Ni H, Wang ZY, Rao Q.
Frameshift mutation and inactivation of ARID1A in an epithelioid sarcoma.
Pathology
2022;
54
:938-941. [PMID:
35346504
DOI:
10.1016/j.pathol.2022.01.002
]
[
Citation(s) in
RCA
: 1
]
[
Impact Index Per Article: 0.5
]
[
Reference Citation Analysis
]
[
What about the content of this article? (
0
)
]
[
Track Full Text
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 08/30/2021]
[Revised: 12/27/2021]
[Accepted: 01/03/2022]
[Indexed: 02/07/2023]
Number
Cited by Other Article(s)
1
Del Savio E
, Maestro R. Beyond SMARCB1 Loss: Recent Insights into the Pathobiology of Epithelioid Sarcoma.
Cells
2022;
11
:cells11172626. [PMID:
36078034
PMCID:
PMC9454995
DOI:
10.3390/cells11172626
]
[
Citation(s) in
RCA
: 0
]
[
Impact Index Per Article: 0
]
[
Reference Citation Analysis
]
[
Abstract
]
[
MESH Headings
]
[
Track Full Text
]
[
Download PDF
]
[
Figures
]
[
Journal Information
]
[
Subscribe
]
[
Scholar Register
]
[Received: 07/28/2022]
[Revised: 08/22/2022]
[Accepted: 08/23/2022]
[Indexed: 11/16/2022]
Open
Abstract
Epithelioid sarcoma (ES) is a very rare and aggressive mesenchymal tumor of unclear origin and uncertain lineage characterized by a prevalent epithelioid morphology. The only recurrent genetic alteration reported in ES as yet is the functional inactivation of SMARCB1 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1), a key component of the SWI/SNF (SWItch/Sucrose Non-Fermentable) chromatin remodeling complexes. How SMARCB1 deficiency dictates the clinicopathological characteristics of ES and what other molecular defects concur to its malignant progression is still poorly understood. This review summarizes the recent findings about ES pathobiology, including defects in chromatin remodeling and other signaling pathways and their role as therapeutic vulnerabilities.
Collapse
Key Words
Collapse
MESH Headings
Chromatin Assembly and Disassembly
Chromosomal Proteins, Non-Histone/genetics
Chromosomal Proteins, Non-Histone/metabolism
DNA-Binding Proteins/metabolism
Humans
SMARCB1 Protein/genetics
SMARCB1 Protein/metabolism
Sarcoma/pathology
Transcription Factors/genetics
Transcription Factors/metabolism
Collapse
Grants
Collapse
Affiliation(s)
Elisa Del Savio
Roberta Maestro
Correspondence:
Collapse
Page 1 of 1
1
Loading…
Loading…
Export Articles to File
Export Citation Analysis
Export Citation Analysis
Article Number From
to
A maximum of 600 records can be exported at a time.
Format:
*
Excel
Plain Text
PDF
WORD
Invalid value
Loading…
Click to Download the Exported File
Loading…
Loading…
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Select the Category
Loading…
Loading…
Impact Index Per Article
Calculation for Impact Index Per Article
Times Cited ÷ Number of Years = Impact Index Per Article
TM
Loading…